Detalhe da pesquisa
1.
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.
Proc Natl Acad Sci U S A
; 110(10): 3991-6, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23431163
2.
Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules.
Acta Crystallogr D Biol Crystallogr
; 70(Pt 1): 68-78, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24419380